Published in Radiat Res on March 01, 2010
Theoretical analysis of the dose dependence of the oxygen enhancement ratio and its relevance for clinical applications. Radiat Oncol (2011) 0.90
Biology of high single doses of IORT: RBE, 5 R's, and other biological aspects. Radiat Oncol (2017) 0.79
Bioeffect modeling and equieffective dose concepts in radiation oncology--terminology, quantities and units. Radiother Oncol (2012) 2.49
Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. Int J Radiat Oncol Biol Phys (2004) 2.12
Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial. J Clin Oncol (2005) 1.90
Measuring proliferation in breast cancer: practicalities and applications. Breast Cancer Res (2006) 1.68
Transition in survival from low-dose hyper-radiosensitivity to increased radioresistance is independent of activation of ATM Ser1981 activity. Int J Radiat Oncol Biol Phys (2007) 1.41
An image analysis-based approach for automated counting of cancer cell nuclei in tissue sections. Cytometry A (2003) 1.34
Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model. Mol Cancer Ther (2004) 1.30
Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model. BMC Cancer (2007) 1.16
The effects of G2-phase enrichment and checkpoint abrogation on low-dose hyper-radiosensitivity. Int J Radiat Oncol Biol Phys (2010) 1.09
Target validation of cytochrome P450 CYP1B1 in prostate carcinoma with protein expression in associated hyperplastic and premalignant tissue. Int J Radiat Oncol Biol Phys (2004) 1.08
Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer. Breast Cancer Res (2006) 1.08
The confluence of stereotactic ablative radiotherapy and tumor immunology. Clin Dev Immunol (2011) 1.05
Identification of lineage-uncommitted, long-lived, label-retaining cells in healthy human esophagus and stomach, and in metaplastic esophagus. Gastroenterology (2012) 1.05
Effects of exposure to low-dose-rate (60)co gamma rays on human tumor cells in vitro. Radiat Res (2002) 0.98
Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model. Radiat Res (2006) 0.98
Early dose response to yttrium-90 microsphere treatment of metastatic liver cancer by a patient-specific method using single photon emission computed tomography and positron emission tomography. Int J Radiat Oncol Biol Phys (2009) 0.96
Development of a tissue array for primary melanoma with long-term follow-up: discovering melanoma cell adhesion molecule as an important prognostic marker. Plast Reconstr Surg (2005) 0.96
Sorafenib and radiation: a promising combination in colorectal cancer. Int J Radiat Oncol Biol Phys (2010) 0.95
Toxicity from radiation in breast cancer. Cancer Treat Res (2006) 0.94
Evaluation of the deformation and corresponding dosimetric implications in prostate cancer treatment. Phys Med Biol (2012) 0.94
MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation. Int J Radiat Oncol Biol Phys (2011) 0.94
MIRD continuing education: Bystander and low dose-rate effects: are these relevant to radionuclide therapy? J Nucl Med (2007) 0.94
Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injury. Radiother Oncol (2011) 0.91
Multiple biomarker tissue microarrays: bioinformatics and practical approaches. Cancer Metastasis Rev (2008) 0.91
How to overcome (and exploit) tumor hypoxia for targeted gene therapy. J Cell Physiol (2003) 0.91
Estimating the lowest detectable dose of ionizing radiation by the cytokinesis-block micronucleus assay. Radiat Res (2013) 0.90
Correlation of spectral imaging and visual grading for the quantification of thymidylate synthase protein expression in rectal cancer. Hum Pathol (2005) 0.90
Correlation of admissions statistics to graduate student success in medical physics. J Appl Clin Med Phys (2014) 0.90
Validation of tissue microarray for the immunohistochemical profiling of melanoma. Melanoma Res (2004) 0.89
Biological effect of different IMRT delivery techniques: SMLC, DMLC, and helical tomotherapy. Med Phys (2010) 0.89
International Conference on Advances in Radiation Oncology (ICARO): outcomes of an IAEA meeting. Radiat Oncol (2011) 0.89
Soy isoflavones augment radiation effect by inhibiting APE1/Ref-1 DNA repair activity in non-small cell lung cancer. J Thorac Oncol (2011) 0.88
TMPRSS2/ERG fusion gene expression alters chemo- and radio-responsiveness in cell culture models of androgen independent prostate cancer. Prostate (2011) 0.88
Education and training for radiation scientists: radiation research program and American Society of Therapeutic Radiology and Oncology Workshop, Bethesda, Maryland, May 12-14, 2003. Radiat Res (2003) 0.86
Hypofractionation: what does it mean for prostate cancer treatment? Int J Radiat Oncol Biol Phys (2010) 0.85
An assessment of PTV margin based on actual accumulated dose for prostate cancer radiotherapy. Phys Med Biol (2013) 0.85
Effect of imidazole on the solubility of a his-tagged antibody fragment. Hybrid Hybridomics (2003) 0.84
Radiosensitization of colon cancer cell lines by docetaxel: mechanisms of action. Oncol Res (2004) 0.83
Radioprotection of lung tissue by soy isoflavones. J Thorac Oncol (2013) 0.82
CD44v3 levels in primary cutaneous melanoma are predictive of prognosis: assessment by the use of tissue microarray. Int J Cancer (2006) 0.82
Gene expression-based detection of radiation exposure in mice after treatment with granulocyte colony-stimulating factor and lipopolysaccharide. Radiat Res (2011) 0.82
Low-dose hyperradiosensitivity of human glioblastoma cell lines in vitro does not translate into improved outcome of ultrafractionated radiotherapy in vivo. Int J Radiat Biol (2005) 0.82
Detailed characterization of the early response of head-neck cancer xenografts to irradiation using (18)F-FDG-PET imaging. Int J Radiat Oncol Biol Phys (2012) 0.82
Differential effect of soy isoflavones in enhancing high intensity radiotherapy and protecting lung tissue in a pre-clinical model of lung carcinoma. Radiother Oncol (2013) 0.82
Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy. Clin Cancer Res (2004) 0.81
Helical TomoTherapy versus sterotactic Gamma Knife radiosurgery in the treatment of single and multiple brain tumors: a dosimetric comparison. J Appl Clin Med Phys (2010) 0.81
Monitoring sunitinib-induced vascular effects to optimize radiotherapy combined with soy isoflavones in murine xenograft tumor. Transl Oncol (2011) 0.81
Identification of P-cadherin in primary melanoma using a tissue microarrayer: prognostic implications in a patient cohort with long-term follow up. Ann Plast Surg (2005) 0.81
Pulsed low-dose irradiation of orthotopic glioblastoma multiforme (GBM) in a pre-clinical model: effects on vascularization and tumor control. Radiother Oncol (2013) 0.81
B-DIM impairs radiation-induced survival pathways independently of androgen receptor expression and augments radiation efficacy in prostate cancer. Cancer Lett (2011) 0.80
The evaluation of low dose hyper-radiosensitivity in normal human skin. Radiother Oncol (2004) 0.80
Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin. Cancer Gene Ther (2005) 0.80
Radiation-induced adaptive response is not seen in cell lines showing a bystander effect but is seen in lines showing HRS/IRR response. Int J Radiat Biol (2009) 0.80
In vivo cell kinetic measurements in a randomized trial of continuous hyperfractionated accelerated radiotherapy with or without mitomycin C in head-and-neck cancer. Int J Radiat Oncol Biol Phys (2003) 0.80
Single-fraction spine SBRT end-to-end testing on TomoTherapy, Vero, TrueBeam, and CyberKnife treatment platforms using a novel anthropomorphic phantom. J Appl Clin Med Phys (2015) 0.80
Tumor irradiation followed by intratumoral cytokine gene therapy for murine renal adenocarcinoma. Cancer Gene Ther (2004) 0.79
Determining if low dose hyper-radiosensitivity (HRS) can be exploited to provide a therapeutic advantage: a cell line study in four glioblastoma multiforme (GBM) cell lines. Int J Radiat Biol (2013) 0.79
Relationships among micronuclei, nucleoplasmic bridges and nuclear buds within individual cells in the cytokinesis-block micronucleus assay. Mutagenesis (2013) 0.79
Fast neutron irradiation for prostate cancer. Cancer Metastasis Rev (2002) 0.79
Molecular biomarkers and site of first recurrence after radiotherapy for head and neck cancer. Eur J Cancer (2004) 0.79
Pulsed versus conventional radiation therapy in combination with temozolomide in a murine orthotopic model of glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2013) 0.79
"SABER": A new software tool for radiotherapy treatment plan evaluation. Med Phys (2010) 0.79
Design of quality assurance for sonographic prostate brachytherapy needle guides. J Ultrasound Med (2002) 0.79
Effect of respiratory motion on the delivery of breast radiotherapy using SMLC intensity modulation. Med Phys (2007) 0.79
Effects of dose scaling on delivery quality assurance in tomotherapy. J Appl Clin Med Phys (2012) 0.78
nm23 as a prognostic marker in primary cutaneous melanoma: evaluation using tissue microarray in a patient group with long-term follow-up. Melanoma Res (2005) 0.78
The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma. Radiother Oncol (2004) 0.78
SPIN: Development of sample-specific protein integrity numbers as an index of biospecimen quality. Biopreserv Biobank (2013) 0.78
Significant dose can be lost by extended delivery times in IMRT with x rays but not high-LET radiations. Med Phys (2010) 0.78
A novel method of boron delivery using sodium iodide symporter for boron neutron capture therapy. J Radiat Res (2010) 0.77
Soy Isoflavones Promote Radioprotection of Normal Lung Tissue by Inhibition of Radiation-Induced Activation of Macrophages and Neutrophils. J Thorac Oncol (2015) 0.77
The effect of neutron radiation on conventional and highly cross-linked ultrahigh-molecular-weight polyethylene wear. J Arthroplasty (2008) 0.77
Gene expression changes associated with the progression of intraductal papillary mucinous neoplasms. Pancreas (2012) 0.77
Boron neutron capture enhancement of fast neutron radiotherapy utilizing a moderated fast neutron beam. Med Phys (2005) 0.76
A simulation to analyze feature selection methods utilizing gene ontology for gene expression classification. J Biomed Inform (2013) 0.76
Intensity modulated neutron radiotherapy for the treatment of adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys (2007) 0.76
Use of oncogene expression as an independent prognostic marker for primary melanoma. Ann Plast Surg (2003) 0.76
Ultrafractionation does not improve the results of radiotherapy in radioresistant murine DDL1 lymphoma. Strahlenther Onkol (2005) 0.76
Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinoma. Int Urol Nephrol (2013) 0.75
Gene Expression Characterization of HPV Positive Head and Neck Cancer to Predict Response to Chemoradiation. Head Neck Pathol (2014) 0.75
Technical evaluation of TomoTherapy automatic roll correction. J Appl Clin Med Phys (2015) 0.75
Dosimetric comparison of helical tomotherapy treatment plans for total marrow irradiation created using GPU and CPU dose calculation engines. Med Phys (2013) 0.75
Intensity modulated neutron radiotherapy optimization by photon proxy. Med Phys (2012) 0.75
Differences in cytogenetic sensitivity to ionizing radiation in newborns and adults. Radiat Res (2014) 0.75
Dose escalation in prostate cancer using intensity modulated neutron radiotherapy. Radiother Oncol (2011) 0.75
Comprehensive evaluation and clinical implementation of commercially available Monte Carlo dose calculation algorithm. J Appl Clin Med Phys (2013) 0.75
Dose escalation using a hypofractionated, intensity-modulated radiation therapy boost for localized prostate cancer: preliminary results addressing concerns of high or low alpha/beta ratio. Clin Genitourin Cancer (2009) 0.75